Skip to main content

Advertisement

SpringerLink
Log in

Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System

  • Invited Review
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

This review will provide an in-depth discussion on the previous development of nanoparticle-based drug delivery systems (DDS) and discuss original research data that includes the therapeutic enhancement of antiretroviral therapy. The use of nanoparticle DDS will allow practitioners to use drugs to target specific areas of the body. In the treatment of malignancies, the use of nanoparticles as a DDS is making measurable treatment impact. Medical imaging will also utilize DDS to illuminate tumors, the brain, or other cellular functions in the body. The utility of nanoparticle DDS to improve human health is potentially enormous.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593–623

    PubMed  CAS  Google Scholar 

  • Alder-Moore J (1994) AmBisome targeting to fungal infections. Bone Marrow Transplant 14(Suppl 5):S3–S7

    Google Scholar 

  • Allen TM (1998) Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 56:747–756

    PubMed  CAS  Google Scholar 

  • Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822

    PubMed  CAS  Google Scholar 

  • Anzai Y (2004) Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 15:103–111

    PubMed  Google Scholar 

  • Beck P, Kreuter J, Reszka R, Fichtner I (1993) Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of anticancer drug mitoxantrone in murine tumour models. J Microencapsul 10:101–114

    PubMed  CAS  Google Scholar 

  • Bender A, Schfer V, Steffan AM, Royer C, Kreuter J, Rubsamen-Waigmann H, von Briesen H (1994) Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. Res Virol 145:215–220

    PubMed  CAS  Google Scholar 

  • Bory C, Boulieu R, Souillet G, Chantin C, Guibaud P, Hershfield MS (1991) Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. Adv Exp Med Biol 309A:173–176

    PubMed  CAS  Google Scholar 

  • Bressler NM (2001) Verteporfin therapy of suboveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541–560

    Google Scholar 

  • Cabanes A, Briggs KE, Gokhale PC, Treat JA, Rahman A (1998) Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. Int J Oncol 12:1035–1040

    PubMed  CAS  Google Scholar 

  • Caliceti P (2004) Pharmacokinetics of pegylated interferons: what is misleading? Dig Liver Dis 36(Suppl 3):S334–S339

    PubMed  CAS  Google Scholar 

  • Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, el Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A (2006) Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 24:1443–1448

    PubMed  CAS  Google Scholar 

  • Cheng TL, Cheng CM, Chen BM, Tsao Da, Chuang KH, Hsiao SW, Lin YH, Roffler SR (2005) Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. Bioconjug Chem 16:1225–1231

    PubMed  CAS  Google Scholar 

  • Cline MJ, Lehrer RI, Terrio MD, Golde DW (1978) Monocytes and macrophages: functions and diseases. Ann Intern Med 88:78–88

    PubMed  CAS  Google Scholar 

  • Conway MA, Madrigal-Estebas L, McClean S, Brayden DJ, Mills KH (2001) Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 19:1940–1950

    PubMed  CAS  Google Scholar 

  • Couvreur P, Kante B, Crislain L, Roland M, Speiser P (1982) Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J Pharm Sci 71:790–792

    PubMed  CAS  Google Scholar 

  • Cynamon MH, Swenson CE, Palmer GS, Ginsberg RS (1989) Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 33:1179–1183

    PubMed  CAS  Google Scholar 

  • Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, Triller A (2003) Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302:442

    PubMed  CAS  Google Scholar 

  • Dembri A, Montisci MJ, Gantier JC, Chacun H, Ponchel G (2001) Targeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(ioshexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues. Pharm Res 18:467–473

    PubMed  CAS  Google Scholar 

  • Dou H, Destache CJ, Morehead JR, Losley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE (2006) A macrophage nanoparticle system for anti-retroviral drug delivery: pharmacokinetic, immune and anti-viral responses in a murine model of HIV-1 disease. Blood (in press)

  • Douglas SJ, Davis SS, Illum L (1987) Nanoparticles in drug delivery. Crit Rev Ther Drug Carr Syst 3:233–261

    CAS  Google Scholar 

  • Ferrari M (2005) Nanovector therapeutics. Curr Opin Chem Biol 9:343–346

    PubMed  CAS  Google Scholar 

  • Fiegel J, Fu J, Hanes J (2004) Poly(ether-anhydride drug powder aerosols for sustained drug delivery in the lungs. J Control Release 96:411–423

    PubMed  CAS  Google Scholar 

  • Fielding RM, Lewis RO, Moon-McDermott L (1998) Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharm Res 15:1775–1781

    PubMed  CAS  Google Scholar 

  • Fishbein I, Chorny M, Banai S, Levitzki A, Danenberg HD, Gao J, Chen X, Moerman E, Gati I, Boldwasser V, Golomb G (2001) Formulation and delivery mode affect disposition and activity of tryphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol 21:1434–1439

    PubMed  CAS  Google Scholar 

  • Galeska I, Kim T-K, Patil SD, Bhardwaj U, Chatttopadhyay D, Papadimitrakopoulos F, Burgess DJ (2005) Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J 7:E231–E240

    PubMed  CAS  Google Scholar 

  • Gao X, Cui Y, Levenson RM, Chung LW, Nie S (2004) In vivo cancer targeting and imaging with semi-conductor quantum dots. Nat Biotechnol 22:969–970

    PubMed  CAS  Google Scholar 

  • Gbadamosi JK, Hunter AC, Moghimi SM (2002) PEGylation of microspheres generates a heterogeneous population of particles with different surface characteristics and biological performance. FEBS Lett 532:338–344

    PubMed  CAS  Google Scholar 

  • Gelperina S, Kisich K, Iseman MD, Heifets L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172:1487–1490

    PubMed  Google Scholar 

  • Gensini GF, Conti AA, Lippi D (2006) The 150th anniversary of the birth of Paul Ehrlich, chemotherapy pioneer. J Infect Mar 29 (in press)

  • Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell SB (1999a) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394–3402

    PubMed  CAS  Google Scholar 

  • Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR, Phuphanich S, Rogers LR, Gutheil JC, Batchelor T, Lyter D, Chamberlain M, Maria BL, Schiffer C, Bashir R, Thomas D, Cowens W, Howell SB (1999b) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110–3116

    PubMed  CAS  Google Scholar 

  • Glue P, Pouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S, Clement RP (2000) A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. Hepatology 32:647–657

    PubMed  CAS  Google Scholar 

  • Gruenberg J (2001) The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2:721–730

    PubMed  CAS  Google Scholar 

  • Gryziewicz L (2005) Regulator aspects of drug approval for macular degeneration. Adv Drug Deliv Rev 57:2092–2098

    PubMed  CAS  Google Scholar 

  • Henson PM, Henson JE, Fittschen C (1988) Phagocytic cells: degranulation and secretion. In: Callin JI, Goldstein IM, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates. Ranin Press, New York, NY, pp 363–390

    Google Scholar 

  • Hirsch JG (1962) Cinemicrophotographic observations on granule lysis in polymorphonuclear leucocytes during phagocytosis. J Exp Med 116:827–833

    PubMed  CAS  Google Scholar 

  • Hitzman CJ, Elmquist WF, Wattenberg LW, Wiedmann TS (2006) Development of a respirable, sustained release microcarrier for 5-fluorouracil I: in vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci 95:1114–1126

    PubMed  CAS  Google Scholar 

  • Hoag H (2006) Seeing the big picture. Nature 440:1084–1085

    PubMed  CAS  Google Scholar 

  • Hofheinz R-D, Gnad-Vogt SU, Beyer U, Hochhaus A (2005) Liposomal encapsulated anti-cancer drugs. Anti-Cancer Drugs 16:691–707

    PubMed  CAS  Google Scholar 

  • Hohng S, Ha T (2004) Near-complete suppression of quantum dot blinking in ambient conditions. J Am Chem Soc 126:1324

    PubMed  CAS  Google Scholar 

  • Jacobson IM, Gonzalez SA, Ahmed F, Lebovics E, Min AD, Bodenheimer HC Jr, Esposito SP, Brown RS Jr, Brau N, Klion FM, Tobias H, Bini EJ, Brodsky N, Cerulli MA, Aytaman A, Gardner PW, Geders JM, Spivack JE, Rahmin MG, Berman DH, Ehrlich J, Russo MW, Chait M, Rovner D, Edlin BR (2005) A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol 100:2453–2462

    PubMed  CAS  Google Scholar 

  • Jaiswal JK, Mattoussi J, Mauro JM, Simon SM (2003) Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21:47–51

    PubMed  CAS  Google Scholar 

  • Jayewardene AL, Zhu F, Aweeka FT, Gambertoglio JG (1998) Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma. J Chromatogr B Biomed Sci Appl 707:203–211

    PubMed  CAS  Google Scholar 

  • Johnson CM, Pandey R, Sharma S, Khuller GK, Basaraba RJ, Orme IM, Lenaerts AJ (2005) Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis. Antimicrob Agents Chemother 49:4335–4338

    PubMed  CAS  Google Scholar 

  • Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Rawil A, Khalifa KE, He O, Koziel MJ, El Niggar KM, Rasenack J, Afdhal NH (2006) Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 130:632–638

    PubMed  CAS  Google Scholar 

  • Kato T, Nemoto R, Mori H, Abe R, Unno K, Goto A, Murota H, Harada M, Homma M (1984) Magnetic microcapsules for targeted delivery of anticancer drugs. Appl Biochem Biotechnol 10:199–211

    PubMed  CAS  Google Scholar 

  • Kim CK, Lim SJ (2002) Recent progress in drug delivery systems for anticancer agents. Arch Pharm Res 25:229–239

    Article  PubMed  CAS  Google Scholar 

  • Kim S, Chatelut E, Kim JC, Howell SB, Cates C, Kormanik PA, Chamberlain MC (1993) Extended CSF cytarabine exposure following intrathecal administration of DTD 101. J Clin Oncol 11:2186–2193

    PubMed  CAS  Google Scholar 

  • Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Kanayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Fangioni JV (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93–97

    PubMed  CAS  Google Scholar 

  • Kipp JE (2004) The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 284:109–122

    PubMed  CAS  Google Scholar 

  • Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003) In vivo high-resolution three dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63:6838–6846

    PubMed  CAS  Google Scholar 

  • Kontermann RE (2006) Immunoliposomes for cancer therapy. Curr Opin Mol Ther 8:39–45

    PubMed  CAS  Google Scholar 

  • Kreuter J (1978) Nanoparticles and nanocapsules—new dosage forms in the nanometer size range. Pharm Acta Helv 53:33–39

    PubMed  CAS  Google Scholar 

  • Kreuter J (1983) Evaluation of nanoparticles as drug-delivery systems. III. Materials, stability, toxicity, possibilities of targeting, and use. Pharm Acta Helv 58:242–250

    PubMed  CAS  Google Scholar 

  • Lacoste TD, Michalet X, Pinaud F, Chemla DS, Alivisatos Ap, Weiss S (2000) Ultrahigh-resolution multicolor colocalization of single fluorescent probes. Proc Natl Acad Sci USA 97:9461

    PubMed  CAS  Google Scholar 

  • Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchii H, Maincent P, Kawashima Y, Lehr CM (2001) Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 299:775–781

    PubMed  CAS  Google Scholar 

  • LaVan DA, McGuire T, Langer R (2003) Small-scale systems for in vivo drug delivery. Nat Biotechnol 21:1184–1191

    PubMed  CAS  Google Scholar 

  • Laverman P, Dams ET, Storm G, Hafmans TG, Croes HJ, Oven WJ, Corstens FH, Boerman OC (2001) Microscopic localization of PEG-liposomes in a rat model of focal infection. J Control Release 75:347–355

    PubMed  CAS  Google Scholar 

  • Lee CC, MacKay JA, Frechet JM, Szoka FC (2005a) Designing dendrimers for biological applications. Nat Biotechnol 23:1517–1526

    PubMed  CAS  Google Scholar 

  • Lee JH, Canny MD, Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F (2005b) A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci USA 102:18902–18907

    PubMed  CAS  Google Scholar 

  • Leroux JC, Cozens R, Roesel JL, Galli B, Kubel F, Doelker E, Gurny R (1995) Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci 84:1387–1391

    PubMed  CAS  Google Scholar 

  • Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco HE, Jares-Erijman EA, Jovin TM (2004) Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 22:198–203

    PubMed  CAS  Google Scholar 

  • Lobenberg R, Kreuter J (1996) Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy. AIDS Res Hum Retrovir 10:1709–1715

    Google Scholar 

  • Lobenberg R, Araujo L, von Beirsen J, Rodgers E, Kreuter J (1998) Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. J Control Release 50:21–30

    PubMed  CAS  Google Scholar 

  • Luck M, Paulke BR, Schroder W, Blunk T, Muller RH (1998) Analysis of plasma protein adsoption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res 39:478–485

    PubMed  CAS  Google Scholar 

  • Luster AD, Rothenburg ME (1997) Role of the monocytes chemoattractant protein and eotoxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 62:620–633

    PubMed  CAS  Google Scholar 

  • Lysik MA, Wu-Pong S (2003) Innovations in oligonucleotide drug delivery. J Pharm Sci 92:1559–1579

    PubMed  CAS  Google Scholar 

  • Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284

    PubMed  CAS  Google Scholar 

  • Mansson A, Sundberg M, Balaz, Bunk R, Nicholls IA, Omling P, Tagerud S, Montelius L (2004) In vitro sliding of acting filaments labeled with single quantum dots. Biochem Biophys Res Commun 314:529–534

    PubMed  CAS  Google Scholar 

  • Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538–544

    PubMed  CAS  Google Scholar 

  • Moghimi SM, Hunter AC (2001) Capture of stealth nanoparticles by the body's defences. Crit Rev Ther Drug Carr Syst 18:527–550

    CAS  Google Scholar 

  • Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–467

    PubMed  CAS  Google Scholar 

  • Moghimi SM, Muir IS, Illum L, Davis SS, Kolb-Bachofen V (1993) Coating particle with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of the dysopsonins in the serum. Biochim Biophys Acta 1179:157–165

    PubMed  CAS  Google Scholar 

  • Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318

    PubMed  CAS  Google Scholar 

  • Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19:11–30

    Google Scholar 

  • Muggia F, Hamilton A (2001) Phase III data on Caelyz in ovarian cancer. Eur J Cancer 37(Suppl 9):S15–S18

    PubMed  CAS  Google Scholar 

  • Murry DJ, Blaney SM (2000) Clinical pharmacology of encapsulated sustained release cytarabine. Ann Pharmacother 34:1173–1178

    PubMed  CAS  Google Scholar 

  • Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627

    PubMed  CAS  Google Scholar 

  • Nirmal M, Norris DJ, Kuno M, Bawendi MG, Efros AL, Rosen M (1995) Observation of the “Dark exciton” in CdSe quantum dots. Phys Rev Lett 75:2731–3728

    Google Scholar 

  • Nobs L, Buchegger F, Gurny R, Allemann E (2004) Current methods for attaching ligands to liposomes and nanoparticles. J Pharm Sci 93:1980–1992

    PubMed  CAS  Google Scholar 

  • Nobuto H, Sugita T, Kubo T, Shimose S, Yasunaga Y, Murakami T, Ochi M (2004) Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 109:627–635

    PubMed  CAS  Google Scholar 

  • Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD (1996) Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36:55–63

    PubMed  CAS  Google Scholar 

  • Nyman DW, Campbell KJ, Hersh E, Long K, Richardson K, Trieu V, Desai N, Hawkins MJ, Von Hoff DD (2005) Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. J Clin Oncol 23:7785–7793

    PubMed  CAS  Google Scholar 

  • Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonerheid E, Jegasothy B, Wood G, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 19:376–388

    PubMed  CAS  Google Scholar 

  • Pandey R, Khuller GK (2004) Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model. J Antimicrob Chemother 54:266–268

    PubMed  CAS  Google Scholar 

  • Pandey R, Khuller GK (2005) Antitubercular inhaled therapy: opportunities, progress and challenges. J Antmicrob Chemother 55:430–435

    CAS  Google Scholar 

  • Pandey R, Sharma A, Zohoor A, Sharma S, Khuller GK, Prasad B (2003) Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 52:981–986

    PubMed  CAS  Google Scholar 

  • Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347

    PubMed  CAS  Google Scholar 

  • Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V (2002) Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16:1217–1226

    PubMed  CAS  Google Scholar 

  • Paul M, Durand R, Boulard Y, Fusai T, Fernandez C, Rivollet D, Deniau M, Astier A (1998) Physiochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice. J Drug Target 5:481–490

    Article  PubMed  CAS  Google Scholar 

  • Perez AT, Domenech GH, Frankel C, Vogel CL (2002) Peglyated liposomal doxorubicin for metastatic breast cancer: the Cancer Research Network, Inc. experience. Cancer Investig 20(Suppl 2):22–29

    CAS  Google Scholar 

  • Persson EM, Gustafsson AS, Carlsson AS, Nilsson RG, Knutson L, Forsell P, Hanisch G, Llennenas H, Abrahamsson B (2005) The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 22:2141–2151

    PubMed  CAS  Google Scholar 

  • Petersein J, Saini S, Weissleder R (1996) Liver. II: iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review. Magn Reson Imaging Clin N Am 4:53–60

    PubMed  CAS  Google Scholar 

  • Pinaud F, King D, Moore HP, Weiss S (2004) Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J Am Chem Soc 126:6115

    PubMed  CAS  Google Scholar 

  • Pinto-Alphandary H, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 13:155–168

    PubMed  CAS  Google Scholar 

  • Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–796

    PubMed  CAS  Google Scholar 

  • Ravi Kumar MN (2000) Nano and microparticles as controlled drug delivery devices. J Pharm Sci 3:234–258

    CAS  Google Scholar 

  • Reddy LH, Sharma RK, Murthy RS (2004) Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour. J Drug Target 12:443–451

    PubMed  CAS  Google Scholar 

  • Rosen O, Muller HJ, Gokbuget N, Langer W, Peter N, Schwartz S, Hahling D, Hartmann F, Ittel TH, Muck R, Rothmann F, Arnold R, Boos J, Hoelzer D (2003) Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult lymphoblastic leukaemia in first remission: a pilot study. Br J Haematol 123:836–841

    PubMed  CAS  Google Scholar 

  • Schiffelers R, Storm G, Bakker-Woudenberg I (2001) Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother 48:333–344

    PubMed  CAS  Google Scholar 

  • Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436:568–572

    PubMed  CAS  Google Scholar 

  • Sharma A, Pandey R, Sharma S, Khuller GK (2004) Chemotherapeutic efficacy of poly (dl-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis. Int J Antimicrob Agents 24:599–604

    PubMed  CAS  Google Scholar 

  • Shenoy D, Little S, Langer R, Amiji M (2005) Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies. Pharm Res 22:2107–2114

    PubMed  CAS  Google Scholar 

  • Siena S, Piccart MJ, Holmes FA, Glaspy J, Hackett J, Renwick JJ (2003) A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily filgrastim in patients with stage II–IV breast cancer. Oncol Rep 10:715–724

    PubMed  CAS  Google Scholar 

  • Singh SS (2006a) Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 7:165–172

    PubMed  CAS  Google Scholar 

  • Singh SS (2006b) Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 7:165–182

    PubMed  CAS  Google Scholar 

  • Sundar S, Jha TK, Thakur CP, Mishra M, Singh VP, Buffels R (2003) Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clin Infect Dis 37:800–804

    PubMed  CAS  Google Scholar 

  • Sundar S, Mehta H, Suresh AV, Singh SP, Rai M, Murray HW (2004) Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 38:377–383

    PubMed  CAS  Google Scholar 

  • Symon Z, Peyser A, Tzemach D, Lyass O, Sucher E, Shezen E, Gabizon A (1999) Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer 86:72–78

    PubMed  CAS  Google Scholar 

  • Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, Shipton MK, Franzen S, Feldheim DL (2004) Cellular trajectories of peptide-modified gold particles complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 15:482–490

    PubMed  CAS  Google Scholar 

  • Torchilin VP (1997) Surface-modified liposomes in γ and MR-imaging. Adv Drug Deliv Rev 24:301–313

    CAS  Google Scholar 

  • Torchilin VP (2000) Drug targeting. Eur J Pharm Sci 11(Suppl 2):S81–S91

    PubMed  CAS  Google Scholar 

  • Torchilin VP (2005a) Lipid-core micelles for targeted drug delivery. Curr Drug Deliv 2:319–327

    PubMed  CAS  Google Scholar 

  • Torchilin VP (2005b) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160

    PubMed  CAS  Google Scholar 

  • Tucker RD, Huidobro C, Larson R, Platz CE (2000) Use of permanent interstitial temperature self-regulating rods for ablation of prostate cancer. J Endourol 14:511–517

    Article  PubMed  CAS  Google Scholar 

  • Vicent MJ, Duncan R (2006) Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol 24:39–47

    PubMed  CAS  Google Scholar 

  • Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulandin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS (2005) First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23:1178–1184

    PubMed  CAS  Google Scholar 

  • Volmink J, Garner P (2000) Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 4:CD000010

    Google Scholar 

  • Walsh TJ, Viviani MA, Arathoon E, Chiou C, Ghannoum M, Groll AH, Odds FC (2000) New targets and delivery systems for antifungal therapy. Med Mycol 38(Suppl 1):335–347

    PubMed  CAS  Google Scholar 

  • Wu XY, Liu H, Lui J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP (2003) Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 21:41–46

    PubMed  CAS  Google Scholar 

  • Ye Q, Asheman J, Stevenson M, Brownson E, Katre NV (2000) DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs. J Control Release 64:155–166

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, 68198-5215, USA

    Jeffrey D. Kingsley, Huanyu Dou, Justin Morehead, Howard E. Gendelman & Christopher J. Destache

  2. Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5215, USA

    Huanyu Dou, Justin Morehead, Howard E. Gendelman & Christopher J. Destache

  3. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198-5215, USA

    Howard E. Gendelman

  4. Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, 68198-5215, USA

    Jeffrey D. Kingsley

  5. Creighton University School of Pharmacy & Health Professions, 2500 California Plaza, Omaha, NE, 68178, USA

    Christopher J. Destache

  6. Baxter Healthcare Corporation, Round Lake, IL, 60073, USA

    Barrett Rabinow

Authors
  1. Jeffrey D. Kingsley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huanyu Dou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Justin Morehead
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Barrett Rabinow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Howard E. Gendelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher J. Destache
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J. Destache.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kingsley, J.D., Dou, H., Morehead, J. et al. Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System. Jrnl Neuroimmune Pharm 1, 340–350 (2006). https://doi.org/10.1007/s11481-006-9032-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-006-9032-4

Key words

Search

Navigation